Other
Irae
0
Pipeline Programs↗
2
Active Trials↗
0
Companies Involved↗
IrAE is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
3
clinical trials
Not yet recruiting1 · 33%
Unknown status1 · 33%
Recruiting1 · 33%
Clinical Trials
Trial Activity
IL-17 Blockade to Decrease irAEs (REPLAY)
Not yet recruiting·—·Phase 1·NCT07237594·4 enrolled
Thymosin Alpha-1 for irAE Secondary to ICIs
Unknown status·—·Phase 4·NCT06178146·40 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)